alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; DDK-B Conflicts.                    

*Date:*                         February 12-13, 2019.                    

*Time:*                         12:00 p.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD 20814.                    

*Contact Person:*                         Thomas A. Tatham, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7021, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-3993,                         *tathamt@mail.nih.gov.*

This meeting notice is being published less than 15 days in advance of the meeting due to the partial Government shutdown of December 2018.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

      ( print page 773)    
Dated: January 25, 2019.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2019-00348 Filed 1-30-19; 8:45 am]

 BILLING CODE 4140-01-P
[Federal Register Volume 69, Number 222 (Thursday, November 18, 2004)]
[Notices]
[Page 67595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-25578]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal property.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel Social Implications of Embryo 
Cryopreservation.
    Date: December 7, 2004.
    Time: 12:30 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6100 Executive Boulevard, 
Room 5B01, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Carla T. Walls, PhD, Scientific Review 
Administrator, Division of Scientific Review, National Institute of 
Child Health and Human Development, NIH, 6100 Executive Blvd., Room 
5B01, Bethesda, MD 20892, (301) 435-6898, <a href="/cdn-cgi/l/email-protection#2d5a4c41415e4e6d404c444103434445034a425b"><span class="__cf_email__" data-cfemail="3245535e5e4151725f535b5e1c5c5b5a1c555d44">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: November 10, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-25578 Filed 11-17-04; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2465 Received in Senate (RDS)]

  1st Session
                                H. R. 2465

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             June 24, 2003

                                Received

_______________________________________________________________________

                                 AN ACT

 
To extend for six months the period for which chapter 12 of title 11 of 
                  the United States Code is reenacted.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Family Farmer Bankruptcy Relief Act 
of 2003''.

SEC. 2. SIX-MONTH EXTENSION OF PERIOD FOR WHICH CHAPTER 12 OF TITLE 11, 
              UNITED STATES CODE, IS REENACTED.

    (a) Amendments.--Section 149 of title I of division C of Public Law 
105-277 (11 U.S.C. 1201 note) is amended--
            (1) by striking ``July 1, 2003'' each place it appears and 
        inserting ``January 1, 2004''; and
            (2) in subsection (a)--
                    (A) by striking ``December 31, 2002'' and inserting 
                ``June 30, 2003''; and
                    (B) by striking ``January 1, 2003'' and inserting 
                ``July 1, 2003''.
    (b) Effective Date.--The amendments made by subsection (a) take 
effect on July 1, 2003.

            Passed the House of Representatives June 23, 2003.

            Attest:

                                                 JEFF TRANDAHL,

                                                                 Clerk.
```
[Federal Register Volume 84, Number 20 (Wednesday, January 30, 2019)]
[Notices]
[Page 474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00275]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Chief Operating 
Officer, CDC, pursuant to Public Law 92-463. The grant applications and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel (SEP)--DP19-005, Research to 
Enhance the US Vision and Eye Health Surveillance System.
    Dates: March 28, 2019.
    Times: 11:00 a.m.-6:00 p.m., EDT.
    Place: Teleconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Jaya Raman Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, 
Georgia 30341, Telephone: (770) 488-6511, <a href="/cdn-cgi/l/email-protection#29425f481c694a4d4a074e465f"><span class="__cf_email__" data-cfemail="caa1bcabff8aa9aea9e4ada5bc">[email protected]</span></a>.

    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal 
Register notices pertaining to announcements of meetings and other 
committee management activities, for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and 
Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-00275 Filed 1-29-19; 8:45 am]
 BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
§ 2.3 Delegation of authority. ( a ) The General Counsel is hereby named as the designee of the Secretary ofCommerce with respect to tort claims filed under section 2672 of Title 28, U.S. Code, as described in § 2.2, with authority to act on such claims as provided in said section 2672, including denial thereof.
( b ) Authority delegated under this section may, with the approval of the General Counsel, be redelegated to other designees.
( c ) Settlement or denial of any claim under this part is final for the Department of Commerce.
[48 FR 31636, July 11, 1983]
IN THE SUPREME COURT OF PENNSYLVANIA

**In the Matter of:**

**JASON JOSEPH MAZZEI :**  **: :**  **: :**  **: :**  **: :**  **No. 2269 Disciplinary Docket No. 3**

**Board File No. C4-14-329**

**United States District Court for the Western District of Pennsylvania Misc. No.**  **14-568 Attorney Registration No.**  **83775**

ORDER

PER CURIAM

AND NOW **, this 10 th**  **day of August, 2016, upon consideration of the response s to**  **a Notice and Order directing Respondent to provide rea sons against the imposition of a**  **disbarment reciprocal to that imposed in the United Sta tes Bankruptcy Court and the** 

**United States District Court for the Western District of Pennsylvania, Jason Joseph**  **Mazzei is disbarred from the practice of law in this Co mmonwealth, retroactive to**  **November 20, 2014, and he shall comply with all the p rovisions of Pa.R.D.E. 217.**
Exhibit 32.1

             CERTIFICATION OF PRINCIPAL EXECUTIVE, ACCOUNTING AND
             FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350


In connection with the Quarterly Report of New Pacific Ventures, Inc. (the
"Company") on Form 10-QSB for the period ended January 31, 2004, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I
Brent Petterson, Secretary/Treasurer of the Company, hereby certify pursuant to
18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of
2002, that:

    (1)  the Report fully complies with the requirements of section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

    (2)  the information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations
         of the Company.

/s/Brent Petterson
-------------------
Brent Petterson
Secretary/Treasurer/Director

March 15, 2004
The Secretary of Energy
Washington, DC 20585

DOE-WD-2012-001
March 2012

SECTION 3116 DETERMINATION
FOR CLOSURE OF F-TANK FARM AT THE SAVANNAH RIVER SITE

For the reasons set forth in the attached “Basis for Section 3116 Determination for

Closure of F-Tank Farm at the Savannah River Site," and based on consultation with the U.S.
Nuclear Regulatory Commission, I have determined that the stabilized residuals, tanks, and
ancillary structures at closure in the F Tank Farm, at the Savannah River Site will:

Not require permanent isolation in a deep geologic repository for spent fuel or high-level
radioactive waste;

Have had highly radioactive radionuclides removed to the maximum extent practical;

Not exceed concentration limits for Class C low-level waste as set out in Section 61.55 of
Title 10, Code of Federal Regulations;

Be disposed of in compliance with the performance objectives set out in Subpart C of
Part 61 of Title 10, Code of Federal Regulations;

Be disposed of pursuant to the Department of Energy’s disposal plans developed in
consultation with the U.S. Nuclear Regulatory Commission; and

Be disposed of pursuant to closure plans approved by the State of South Carolina.

Accordingly, pursuant to Section 3116(a) of the Ronald W. Reagan National Defense
Authorization Act for Fiscal Year 2005, the stabilized residuals, tanks and ancillary structures at
closure in the F Tank Farm are not high-level radioactive waste and may be disposed of in place
at the Savannah River Site.

MAR 27 2012 Sho Ge

Date Steven Chu

® Printed with soy ink on recycled paper
### §3682. Control by agencies of the United States

Except as provided in section 3674A of this title, no department, agency, or officer of the United States, in carrying out this chapter, shall exercise any supervision or control, whatsoever, over any State approving agency, or State educational agency, or any educational institution. Nothing in this section shall be deemed to prevent any department, agency, or officer of the United States from exercising any supervision or control which such department, agency, or officer is authorized by law to exercise over any Federal educational institution or to prevent the furnishing of education under this chapter or chapter 34 or 35 of this title in any institution over which supervision or control is exercised by such other department, agency, or officer under authority of law.

(Added Pub. L. 89–358, §3(b), Mar. 3, 1966, 80 Stat. 21, §1782; amended Pub. L. 92–540, title IV, §403(9), Oct. 24, 1972, 86 Stat. 1090; Pub. L. 100–323, §13(b)(6), May 20, 1988, 102 Stat. 574; renumbered §3682 and amended Pub. L. 102–83, §5(a), (c)(1), Aug. 6, 1991, 105 Stat. 406.)

#### **Editorial Notes**

#### Prior Provisions

Provisions similar to those comprising this section were contained in Pub. L. 85–857, Sept. 2, 1958, 72 Stat. 1190, 1201, which was classified to former sections 1663 and 1763 of this title, prior to repeal by sections 4(a) and 3(a)(3) of Pub. L. 89–358, respectively.

#### Amendments

1991—Pub. L. 102–83 renumbered section 1782 of this title as this section and substituted "3674A" for "1774A".

1988—Pub. L. 100–323 substituted "Except as provided in section 1774A of this title, no" for "No".

1972—Pub. L. 92–540 inserted "this chapter or" before "chapter 34 or 35".
NRC ADVISORY COMMITTEE ON THE MEDICAL USES OF 

ISOTOPES SELECTS NEW MEMBER; WILL HOLD 

TELECONFERENCE MEETING FEB. 7

The Nuclear Regulatory Commission has selected Darice Bailey as the State Government 

Representative on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). The 

ACMUI was established in 1958, and advises the NRC on policy and technical issues related to 

the regulation of the medical uses of radioactive material.

Bailey is a health physicist currently serving as the manager of the Radioactive Materials 

Group at the Texas Department of State Health Services, Radiation Control Program in Austin, 

Texas. There she is responsible for the oversight of inspection and enforcement for more than 

2,000 licensees. She also serves as a member of the state’s radiological emergency response 

team. 

Bailey is active in various professional organizations and serves in leadership roles for 

both the Conference of Radiation Control Program Directors and the Organization of Agreement 

States. She has also participated in NRC committee activities for the Ritenour Petition and the 

Medical Event Rulemaking committee. 

Bailey holds a Bachelor of Science degree in Community Health with a minor in Biology 

from East Tennessee State University, in Johnson City, Tenn. She has more than 27 years 

experience in radiation regulation and has long tenure working as a health physicist in California, 

Tennessee and Texas.

In other business, the ACMUI will convene a teleconference meeting on Feb. 7, 2012, to 

discuss the Permanent Implant Brachytherapy Subcommittee Report. 

The teleconference meeting will be held from 12 p.m. to 2 p.m. Eastern Standard Time. 

Any member of the public who wants to participate in the teleconference discussion should 

NRC NEWS

U.S. NUCLEAR REGULATORY COMMISSION

Office of Public Affairs Telephone: 301/415-8200

Washington, D.C. 20555-0001

E-mail: opa.resource@nrc.gov Site: www.nrc.gov

Blog: http://public-blog.nrc-gateway.gov

No. 12-005 January 10, 2012
contact Ashley Cockerham by email at ashley.cockerham@nrc.gov or by telephone at 

240-888-7129.

All ACMUI member biographies and a complete agenda are available on the NRC 

website.

###

NOTE: Anyone wishing to take photos or use a camera to record any portion of a NRC meeting should 

contact the Office of Public Affairs beforehand.

News releases are available through a free Listserv subscription or by clicking on the EMAIL UPDATES 

link on the NRC homepage (www.nrc.gov). E-mail notifications are sent to subscribers when news releases are 

posted to NRC's website. For the latest news, follow the NRC on www.twitter.com/NRCgov.
[Federal Register Volume 69, Number 223 (Friday, November 19, 2004)]
[Notices]
[Page 67749]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-25669]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Center for 
Scientific Review Special Emphasis Panel, November 10, 2004, 10 a.m. to 
November 10, 2004, 4 p.m., Sofitel Lafayette Square Hotel, 806 15th 
Street, NW., Washington, DC 20005 which was published in the Federal 
Register on November 3, 2004, 69 FR 64078-64081.
    The meeting will be held December 3, 2004. The meeting time and 
location remain the same. The meeting is closed to the public.

    Dated: November 15, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-25669 Filed 11-18-04; 8:45 am]
BILLING CODE 4140-01-M
#### § 25.40 Stays ordered by the Department of Justice.

If at any time the Attorney General or an Assistant Attorney General designated by the Attorney General transmits to the authority head a written finding that continuation of the administrative process described in this part with respect to a claim or statement may adversely affect any pending or potential criminal or civil action related to such claim or statement, the authority head shall stay the process and it shall be resumed only upon receipt of the written authorization of the Attorney General.
### §7256. Times and places of sessions

The times and places of sessions of the Court of Appeals for Veterans Claims shall be prescribed by the chief judge.

(Added Pub. L. 100–687, div. A, title III, §301(a), Nov. 18, 1988, 102 Stat. 4115, §4056; renumbered §7256, Pub. L. 102–40, title IV, §402(b)(1), May 7, 1991, 105 Stat. 238; amended Pub. L. 105–368, title V, §512(a)(1), Nov. 11, 1998, 112 Stat. 3341.)

#### **Editorial Notes**

#### Amendments

1998—Pub. L. 105–368 substituted "Court of Appeals for Veterans Claims" for "Court of Veterans Appeals".

1991—Pub. L. 102–40 renumbered section 4056 of this title as this section.

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date of 1998 Amendment

Amendment by Pub. L. 105–368 effective on first day of first month beginning more than 90 days after Nov. 11, 1998, see section 513 of Pub. L. 105–368, set out as a note under section 7251 of this title.
#### Spectrum of Connecticut, Inc. *v.*Planning and Zoning Commission of the Town of Ellington

*Martin A. Clayman,*in support of the petition.

*Atherton B. Ryan,*in opposition.

Decided February 11, 1988

The plaintiff’s petition for certification for appeal from the Appellate Court, 13 Conn. App. 159, is denied.
Exhibit 31.1



Section 302 Certification of Chief Executive Officer and Chief Financial Officer







I, B. Alva Schoomer, certify that:



1.

I have reviewed this quarterly report on Form 10-QSB of BAS Consulting, Inc.



2.

Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;



3.

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;



4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:



a)

designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;



b)

evaluated the effectiveness of the registrants disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the Evaluation Date); and



c)

presented in this quarterly report my conclusions about the effectiveness of the disclosure controls and procedures based on my evaluation as of the Evaluation Date;



5.

I have disclosed, based on my most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):



a)

all significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and



b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls.



6.

I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of my most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.



Date: November 8, 2005



/s/ B. Alva Schoomer



B. Alva Schoomer

Chief Executive Officer and Chief Financial Officer